This page includes Regulatory news filings supplied by issuers listed on the BSX. Please note the BSX is not responsible for the content, accuracy or completeness of announcements filed by issuers and disclaims all liability for any loss arising from reliance on information contained within issuer announcements.
BSX Approves Listing Of The Class A09 USD Non-Voting Redeemable PreferenceShares Of FMG Bio-Med Hedge Fund Ltd.
Hamilton, Bermuda: 16 June 2009 - The Listing Committee of the Bermuda Stock Exchange (BSX) today announced the approval of the listing of 11,988,000 non-voting redeemable preference Class A09 shares each in US dollars or in Euro or in NOK, of the FMG Bio-Med Hedge Fund Ltd. (the "Fund"). The listing was effective from 20 May 2009.
.
The FMG Bio-Med Hedge Fund Ltd. was incorporated on 11 April, 2000. The Fund is a Bermuda Standard Scheme. The investment objective is to create a high return health care related fund by investing primarily with a number of successful health care sector focused managers. The Fund commenced business on 1 May, 2000.
Apex Fund Services Ltd. sponsored the listing of the Ordinary Shares of the FMG Bio-Med Hedge Fund Ltd.
"The BSX is delighted to welcome the FMG Bio-Med Hedge Fund Ltd. to listing", said Mr. James S. McKirdy, Chief Compliance Officer of the BSX.
For further information on the FMG Bio-Med Hedge Fund Ltd. please contact Mr.